
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc is strategically positioned to capitalize on the anticipated stronger Medicare Advantage (MA) rate update for 2026, especially as many managed care organizations are reducing benefits, while Alignment Healthcare gains a funding advantage through its Stars rating. The company's integrated MA-Value-Based Care (VBC) model is expected to drive long-term market share growth and above-average revenue expansion. Additionally, projected gross profit per member per month (PMPM) for initial cohorts ranges between $90-$150, increasing to over $230 PMPM in later years, indicating a positive margin maturation trajectory that could enhance financial performance.
Bears say
Alignment Healthcare Inc's performance indicators suggest potential challenges, particularly as the company operates within a high healthcare utilization environment post-COVID and while navigating complexities associated with value-based care (VBC). Despite demonstrating above-average EBITDA growth and achieving a lower Adjusted Days of Care (ADK) during a time when healthcare needs were rising, the firm faces data friction and inconsistencies in results across various payors and physician groups which may hinder sustainable performance. Additionally, the valuation multiples slightly exceeding the long-term range for peer managed care organizations may indicate an overvaluation relative to the risks presented by operational challenges inherent in their care delivery model.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares